All Surveys & Benchmarking articles – Page 27
-
ArticleFINRA notice outlines key areas for supervising third parties
The Financial Industry Regulatory Authority issued a notice on compliance deficiencies arising from firms’ relationships with vendors culled from examination findings.
-
ArticleBenchmark report explores roadblocks for leadership commitment to compliance
Most risk and compliance professionals feel their senior leaders and managers demonstrate a commitment to their programs overall, but only on a conditional basis, according to the latest NAVEX Global benchmark report.
-
ArticleICA roundtable: Five tips for filing more effective SARs
A recent roundtable explored the anxieties compliance officers face in filing suspicious activity reports and offered advice for overcoming such difficulties.
-
ArticleCompensation report shows CCOs rewarded for pandemic work
Public-sector chief compliance officers in healthcare and life sciences made more than half a million dollars in total compensation in 2020, part of a wave of annual salary increases across the board represented in the latest compensation survey by BarkerGilmore.
-
ArticleLRN survey: E&C programs thrive when boards are engaged
The more boards are engaged in measures of ethics and compliance, the more positive an impact on corporate culture, leadership, and business decisions, a new report from LRN finds.
-
ArticleWhat factors are driving change in your corporate investigations process?
A recent survey from Compliance Week and OpenText reveals while investigations and data volumes are on the rise, machine learning combined with external expertise may give companies the upper hand in accelerating response and results.
-
ArticleICA roundtable: Are companies ready to trust AI?
A recent roundtable on managing resources while confronting regulatory change looked at the importance of balancing machine learning and artificial intelligence with human intelligence and intervention.
-
ArticleQ&A: How Kaiser Permanente has handled change brought by COVID-19
Vanessa Benavides, chief compliance and privacy officer and senior VP at Kaiser Permanente, shares how the company adjusted its policies and procedures because of COVID-19 and the lessons she learned along the way.
-
ArticleFive pieces of advice for potential whistleblowers
Thinking of becoming a whistleblower? The path ahead likely won’t be easy. Learn from others that have been through the process.
-
ArticleReport: Human trafficking undeterred by COVID-19
While many aspects of life over the last year have stagnated because of the pandemic, human trafficking has not slowed down. A new report from the U.S. Department of State explores the latest trends.
-
ArticleSeven things whistleblowers want compliance officers to know
Aaron Nicodemus explains what whistleblowers, their supporters, and advocates would like compliance officers who handle internal complaints to understand about the process from their side of the table.
-
ArticleThe importance of transaction monitoring, and the cost of getting it wrong
Transaction monitoring has evolved to the point where the emphasis is now on the requirement firms carry out ongoing monitoring of client relationships. Recent enforcement actions provide lessons on pitfalls to avoid.
-
ArticleWe bet you’ll love us: Free CW access for month of August
For the month of August, we’re tearing down our paywall. Readers can access our entire archive of news, benchmarking surveys, special reports, case studies, and Webcasts by simply creating a free account and signing in.
-
ArticleThree ideas to improve the whistleblowing process
It’s important to take stock of how far whistleblowing has advanced over the last few years. That said, there is still room for improvement. Aaron Nicodemus offers three suggestions.
-
ArticlePart 5: Waiting for payout a grueling test of tenacity for whistleblowers
The road to a payout for whistleblowers is long, lonely, and full of obstacles. Commitment to the idea that they are doing the right thing helped our whistleblower subjects endure years of hardship to bring their cases to conclusion.
-
ArticleCompliance ramifications of proposed $26B opioid deal for pharma industry
Three major drug distributors and drugmaker Johnson & Johnson reached a proposed $26 billion multistate agreement for their alleged roles in fueling the nationwide opioid epidemic. The settlement imparts compliance lessons on the pharmaceutical industry at large.
-
ArticlePart 4: Retaliation pervades while whistleblowers persevere
Retaliation for blowing the whistle comes in all kinds of forms. Our whistleblower subjects share their stories—from losing jobs to getting blacklisted to being the target of a newspaper hit piece.
-
ArticlePart 3: Blowing the whistle weighs uncertainty against moral duty
Once someone decides to blow the whistle, their life is forever changed. Their action stands to benefit many people they don’t even know while putting much in jeopardy on a personal level. Our whistleblower subjects each explain what led them to their determinations.
-
ArticlePart 2: Internal reporting sends whistleblowers down path alone
Almost no one becomes a whistleblower by choice. A slow and steady whittling down of options often leads individuals to isolation in coming to their decision. Our whistleblower subjects share the roadblocks they faced in reporting internally.
-
ArticlePart 1: Finding the fraud launches whistleblowers on life-changing journey
Whistleblowers aren’t born—they’re made. For five individuals that have taken on that mantle, the story began with discovering a problem that could no longer be ignored.